# | Title | Journal | Year | Citations |
---|
|
1 | Signaling to NF-κB by Toll-like receptors | Trends in Molecular Medicine | 2007 | 2,000 |
2 | MicroRNAs in cancer: biomarkers, functions and therapy | Trends in Molecular Medicine | 2014 | 1,772 |
3 | Nrf2–Keap1 defines a physiologically important stress response mechanism | Trends in Molecular Medicine | 2004 | 1,555 |
4 | DNA damage-induced cell death by apoptosis | Trends in Molecular Medicine | 2006 | 1,299 |
5 | Inflammatory networks during cellular senescence: causes and consequences | Trends in Molecular Medicine | 2010 | 1,102 |
6 | The ‘cytokine profile’: a code for sepsis | Trends in Molecular Medicine | 2005 | 1,068 |
7 | Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide | Trends in Molecular Medicine | 2001 | 1,056 |
8 | Mesenchymal stem cells: building blocks for molecular medicine in the 21st century | Trends in Molecular Medicine | 2001 | 1,027 |
9 | MITF: master regulator of melanocyte development and melanoma oncogene | Trends in Molecular Medicine | 2006 | 1,012 |
10 | RANKL–RANK signaling in osteoclastogenesis and bone disease | Trends in Molecular Medicine | 2006 | 994 |
11 | CD39 and CD73 in immunity and inflammation | Trends in Molecular Medicine | 2013 | 961 |
12 | HIF-1 and tumor progression: pathophysiology and therapeutics | Trends in Molecular Medicine | 2002 | 926 |
13 | Microbiota and neurodevelopmental windows: implications for brain disorders | Trends in Molecular Medicine | 2014 | 881 |
14 | Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology | Trends in Molecular Medicine | 2001 | 841 |
15 | Sialic acids in human health and disease | Trends in Molecular Medicine | 2008 | 827 |
16 | Protein carbonylation in human diseases | Trends in Molecular Medicine | 2003 | 825 |
17 | Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease | Trends in Molecular Medicine | 2008 | 822 |
18 | Carbapenem resistance in Enterobacteriaceae: here is the storm! | Trends in Molecular Medicine | 2012 | 811 |
19 | Tau phosphorylation: the therapeutic challenge for neurodegenerative disease | Trends in Molecular Medicine | 2009 | 804 |
20 | The infant microbiome development: mom matters | Trends in Molecular Medicine | 2015 | 789 |
21 | The tripartite synapse: roles for gliotransmission in health and disease | Trends in Molecular Medicine | 2007 | 737 |
22 | MicroRNA expression and function in cancer | Trends in Molecular Medicine | 2006 | 702 |
23 | Protein S-nitrosylation in health and disease: a current perspective | Trends in Molecular Medicine | 2009 | 686 |
24 | Antibiotic-Induced Changes in the Intestinal Microbiota and Disease | Trends in Molecular Medicine | 2016 | 663 |
25 | Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway | Trends in Molecular Medicine | 2015 | 660 |
26 | The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer | Trends in Molecular Medicine | 2008 | 639 |
27 | Circulating tumour cells in cancer patients: challenges and perspectives | Trends in Molecular Medicine | 2010 | 636 |
28 | Natural regulatory T cells: mechanisms of suppression | Trends in Molecular Medicine | 2007 | 624 |
29 | MUC1: a multifaceted oncoprotein with a key role in cancer progression | Trends in Molecular Medicine | 2014 | 624 |
30 | Hsp90 inhibitors as novel cancer chemotherapeutic agents | Trends in Molecular Medicine | 2002 | 623 |
31 | The role of pyocyanin in Pseudomonas aeruginosa infection | Trends in Molecular Medicine | 2004 | 614 |
32 | Disease Modeling in Stem Cell-Derived 3D Organoid Systems | Trends in Molecular Medicine | 2017 | 612 |
33 | Why have clinical trials in sepsis failed? | Trends in Molecular Medicine | 2014 | 611 |
34 | Quantification using real-time PCR technology: applications and limitations | Trends in Molecular Medicine | 2002 | 609 |
35 | Chemokines and chemokine receptors: new insights into cancer-related inflammation | Trends in Molecular Medicine | 2010 | 608 |
36 | Cell-penetrating peptides: breaking through to the other side | Trends in Molecular Medicine | 2012 | 596 |
37 | Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health | Trends in Molecular Medicine | 2007 | 595 |
38 | Cancer nanomedicine: from targeted delivery to combination therapy | Trends in Molecular Medicine | 2015 | 593 |
39 | The role of selectins in inflammation and disease | Trends in Molecular Medicine | 2003 | 589 |
40 | Estrogen synthesis and signaling pathways during aging: from periphery to brain | Trends in Molecular Medicine | 2013 | 578 |
41 | Endoplasmic reticulum stress, obesity and diabetes | Trends in Molecular Medicine | 2012 | 576 |
42 | Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy | Trends in Molecular Medicine | 2001 | 561 |
43 | Osteoclast-derived activity in the coupling of bone formation to resorption | Trends in Molecular Medicine | 2005 | 559 |
44 | Clinical application of pharmacogenetics | Trends in Molecular Medicine | 2001 | 557 |
45 | Mesenchymal stem cell therapy: Two steps forward, one step back | Trends in Molecular Medicine | 2010 | 555 |
46 | let-7 microRNAs in development, stem cells and cancer | Trends in Molecular Medicine | 2008 | 553 |
47 | NF-κB as a therapeutic target in cancer | Trends in Molecular Medicine | 2002 | 547 |
48 | The Dual Roles of NRF2 in Cancer | Trends in Molecular Medicine | 2016 | 535 |
49 | Pleiotropic effects of statin therapy: molecular mechanisms and clinical results | Trends in Molecular Medicine | 2008 | 532 |
50 | Drug addiction: the neurobiology of disrupted self-control | Trends in Molecular Medicine | 2006 | 516 |